26-0183
Consideration of a Resolution of the Alexandria City Council approving of the City’s participation in the proposed settlement of opioid-related claims on behalf of Alvogen, Inc., Amneal Pharmaceuticals, Inc., Apotex Corp., Hikma Pharmaceuticals USA, Inc., Indivior Inc., Mylan Pharmaceuticals Inc., Sun Pharmaceutical Industries, Inc., and Zydus Pharmaceuticals (USA) Inc. (collectively “the Manufacturers”) and directing the City Attorney and/or the City’s outside counsel to execute the documents necessary to effectuate the City’s participation in the settlements.
- Committee
- City Council Legislative Meeting
- Introduced
- August 27, 2025
- On agenda
- September 9, 2025